A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Recruiting now · Not applicable
Conditions studied: Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion, Ankle Deformity, Ankle Disease, Hindfoot Arthrodesis, Hindfoot Pathologies
In brief
This is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty will be use according to the latest Instructions For Use, standalone in the foot and ankle.
Key facts
- Study ID
- NCT07225751
- Run by
- Kuros Biosurgery AG
- People needed
- 126
- Starts
- 2025-11-25
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2026-07-07
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Steadman Philippon Research Institute — Vail, Colorado, United States (enrolling)
- Hughston Foundation Inc — Columbus, Georgia, United States (enrolling)
- OrthoCarolina Research Institute, Inc — Charlotte, North Carolina, United States (enrolling)
- Reconstructive Orthopaedic Associates II dba Rothman Orthopaedic Institute — Philadelphia, Pennsylvania, United States (enrolling)
- Integrity Orthopedics and Sports Medicine — Chattanooga, Tennessee, United States (enrolling)
- Centers for Advanced Orthopaedics — Falls Church, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.